It appears that the exchange of genetic information is of crucial importance. The prospective genetic market must ensure protection from possible misuse and genetic discrimination in particular. It is particularly important to maintain transparency and equal access to this market.
Zenome aims at creating the personal genomics infrastructure, that would enable participants to:
The principal customers of genetic information are companies interested in genetic targeting such as Google, Facebook, Unilever and pharmaceutical companies.
Inside Zenome Platform different types of information are inextricably intertwined. The nature of each type determines the way to store information of that kind.
Treating data of different kind differently provides privacy as well as scalability of the system.
Since all data transactions, including buying and selling data, are governed by smart-contracts, interactions can only include balances stored on blockchains.
Using any of pre-existing tokens for this purpose would result in unreasonable dependence on the valuation of external token. Thus, a separate utility token should be issued to power economic interactions on the platform.
Development of MVP - IT - DEC 2017
Pilot - MAR 2018
B-version - MAY 2018
Fund Zenome - JUN 2018
Lab partnership - SEP 2018
Creation of the Market - DEC 2018
Big Pharma partnership - MAR 2019
FMCG partnership - AUG 2019
Verified 0%
Attention. There is a risk that unverified members are not actually members of the team
Verified 0%
Attention. There is a risk that unverified members are not actually members of the team
This offer is based solely on information provided by the offeror and other publicly available sources.
The token sale or exchange event is completely independent of ICOholder. ICOholder is not involved in any way, including technical support or promotion.
We list token sales from entities with which we have no relationship to help users track overall activity within the token sector. This information is not intended as advice, and you should seek professional or specialist guidance or conduct your own due diligence before making any decisions based on our content.
Any terms and conditions regarding token acquisition are solely between contributors and the token issuer. ICOholder is not the seller of these tokens.
ICOholder is not legally responsible for any representations made by third parties about any token sale. Any claims for breach of contract must be directed against the listed token issuing entity.
If you have concerns about the nature, legality, or propriety of a token sale or the involved individuals, please contact info@icoholder.com with detailed information.